Restaurant India News: Guttify Set to Raise Rs 20 Cr to Expand Gut Health Offerings Across India

Guttify, the gut health-focused startup launched by Lifechart, is in advanced talks with several venture capital firms to raise Rs 20 crore in its next funding round. The company is gaining traction in the wellness and consumer healthcare segments through its diagnosis-first approach to digestive health.

Sources close to the development suggest that 60 percent of the funding round is likely to be secured through a well-known VC firm with expertise in healthcare and consumer investments. This funding initiative follows the company's recent Rs 3 crore ($360,000) extended seed round in May 2025, which brought Guttify’s total raised capital to over $1 million. Existing investors include the family office of UNICHEM Laboratories.

The startup also recently onboarded Prashant Pitti, Founder of EaseMyTrip and Optimio, as a strategic advisor and investor, further strengthening its advisory and investor base.

Mukul Shah, Co-Founder at Guttify said, “Our mission has always been to help people solve chronic gut health issues from the core using the power of science and diagnostics. The new funding will be used to scale product development, expand distribution, and invest in research to further enhance personalised gut care solutions.”

Guttify plans to use the incoming funds to expand its portfolio of at-home diagnostic tools and wellness products in urban and semi-urban markets across India. A key part of the company's next phase of growth includes the launch of an RNA gene-based DIY gut testing kit, which claims to deliver results within 24 hours. The company aims to make gut testing more accessible and reduce reliance on invasive or clinic-based diagnostic methods.